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Abstract
This research utilizes information theory to study the regulatory roles of
non-coding RNAs in human cancers. microRNAs (miRNA) are small non-
coding RNAs binding to mRNAs to suppress protein expression. Long non-
coding RNAs (lncRNA) can act as competing endogenous RNAs (ceRNAs)
to compete with mRNAs to bind to miRNAs. LncRNAs, miRNAs, and
mRNAs form the ceRNA networks, which play a vital role in regulating
molecular pathways of human cancers. Furthermore, miRNA isoforms, which
are called isomiRs, are also enable to regulate the gene expression and could
be used to distinguish cancer subtypes. Therefore, constructing ceRNA
regulatory networks and identifying isomiRs as cancer subtype biomarkers
are very important for understanding the regulatory role of non-coding RNAs
in cancers.
Current methods for constructing ceRNA networks and discovering
biomarkers that faithfully classify different cancer subtypes have some
limitations. Information theory is a powerful tool for better understanding
the regulatory role of non-coding RNAs in human cancer. This thesis
utilizes information theory for constructing ceRNA network and discovering
human cancer subtype biomarkers in cancers. The novel contributions to the
research field by this thesis are enlisted below:
• A competition rule-based pointwise mutual information is proposed to
construct ceRNA networks.
• An improved mutual information and an information gain are developed




• A distribution-based method is proposed to flitter out the noisy data
in RNA-seq data.
Three case studies have been performed to study the regulatory roles of
non-coding RNAs in human cancers. (1) The first case study is to construct
the competition relationships between lncRNA, miRNA, and mRNA in
breast cancer by using pointwise mutual information. (2) The second case
study is to utilize the improved mutual information to discover isomiR
biomarkers for classifying different breast cancer subtypes. (3) The third
case study applies the improved information gain to detect isomiR based
biomarkers to classify different glioma subtypes.
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